ramucirumab,pembrolizumab
eli lilly,merck
['pembro', 'ramucirumab', 'nsclc', 'sclc']
second-line pembrolizumab plus ramucirumab extends pfs over standard of care in advanced nsclc #asco22
Chief MedOnc @SylvesterCancer. Helping improve Cancer Control in LMICs. Editor-in-Chief @JCOGO_ASCO, Board Member @UICC - co-chair #ATOMcoalition